Alnylam Pharmaceuticals
ALNY
#558
Rank
$42.49 B
Marketcap
$320.43
Share price
-0.60%
Change (1 day)
34.22%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company